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 2 
ABSTRACT 21 
The opportunistic human pathogen Propionibacterium acnes is comprised of a number of 22 
distinct phylogroups, designated types IA1, IA2, IB, IC, II and III, that vary in their 23 
production of putative virulence factors, inflammatory potential, as well as biochemical, 24 
aggregative and morphological characteristics. Although Multilocus Sequence Typing 25 
(MLST) currently represents the gold standard for unambiguous phylogroup classification, 26 
and individual strain identification, it is a labour and time-consuming technique. As a 27 
consequence, we have developed a multiplex touchdown PCR assay that will, in a single 28 
reaction, confirm species identity and phylogeny of an isolate based on its pattern of reaction 29 
with six primer sets that target the 16S rRNA (all isolates), ATPase (type IA1, IA2, IC), sodA 30 
(type IA2, IB), atpD (type II) and recA (type III) housekeeping genes, as well as a Fic family 31 
toxin gene (type IC). When applied to 312 P. acnes isolates previously characterised by 32 
MLST, and representing type IA1 (n=145), IA2 (n=20), IB (n=65), IC (n=7), II (n=45) and III 33 
(n=30), the multiplex displayed 100% sensitivity and 100% specificity for the detection of 34 
isolates within each targeted phylogroup. No cross-reactivity with isolates from other 35 
bacterial species was observed. The multiplex assay will provide researchers with a rapid, 36 
high-throughput and technically undemanding typing method for epidemiological and 37 
phylogenetic investigations. It will facilitate studies investigating the association of lineages 38 
with various infections and clinical conditions, as well as a pre-screening tool to maximise 39 
the number of genetically diverse isolates selected for downstream, higher resolution 40 
sequence-based analyses.   41 
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 3 
INTRODUCTION 42 
Propionibacterium acnes is an anaerobic-to-aerotolerant Gram-positive bacterium which 43 
exists in nature as a human commensal and opportunistic pathogen. It is a major component 44 
of the human skin microbiota, but can also be recovered from the oral cavity, gastrointestinal 45 
and genitourinary tracts (1). Although P. acnes is the main cause of opportunistic human 46 
infections within the ‘cutaneous’ group of propionibacteria, and is well known for its 47 
association with the inflammatory skin condition acne vulgaris (2, 3), its role in other human 48 
infections and clinical conditions is likely to have been significantly underestimated (4-6). 49 
Despite this, we now see a growing recognition that the bacterium is an important cause of 50 
human disease, especially in relation to indwelling medical device-related infections (7-12), 51 
and may also play a role in chronic conditions that cause significant morbidity and mortality, 52 
including low back pain associated with modic type I changes (13), sarcoidosis (14, 15) and 53 
prostate cancer (16, 17). 54 
Within the last ten years, phylogenetic studies based on single and multilocus gene 55 
sequencing (18-21), as well as whole genome analyses of isolates from the Human 56 
Microbiome Project (HMP) and other studies (22-28), have provided valuable insights into 57 
the genetic population structure of P. acnes, particularly in the context of health and disease. 58 
The bacterium has an overall clonal structure and isolates can be classified into a number of 59 
statistically significant clades or phylogroups, designated types IA1, IA2, IB, IC, II and III, 60 
which appear to display differences in their association with specific types of infections (20-61 
21), and also vary in their production of putative virulence determinants (19, 20, 29-32), 62 
inflammatory potential (33-36), antibiotic resistance (21, 37), aggregative properties (16) and 63 
morphological characteristics (19). In particular, a number of independent epidemiological 64 
studies have shown a strong association between clonal complexes from the type IA1 65 
phylogroup and moderate-to-severe acne, while lineages from all other divisions appear more 66 
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frequently isolated from medical device and soft tissue infections, or associated with health as 67 
true commensals (20, 21, 31, 38). Despite these associations, much uncertainty still exists 68 
regarding their exact clinical relevance, particularly in the context of acne where skin 69 
sampling methods may not be optimal or appropriate (39), as well as the wider issue of 70 
whether isolates recovered from different clinical samples are truly representative of infection 71 
in all contexts, or are simply skin contaminants/ passive bystanders within a sample; such 72 
issues are common when dealing with an opportunistic pathogen that is also part of the 73 
normal microbiota, and untangling clinically relevant isolates from background contaminants 74 
can be a challenge. Future studies aimed at addressing such issues will undoubtedly provide a 75 
more solid platform on which we can make definite conclusions regarding the association of 76 
specific P. acnes phylogroups with human disease.  77 
To date, a number of phenotypic and/ or molecular approaches have been investigated 78 
as methods for phylogroup identification, ranging from very simple biochemical tests based 79 
on haemolysis (19) or fermentation profiles (40), to matrix assisted laser 80 
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) (41), monoclonal 81 
antibody (mAb) typing (18) and DNA-based analysis; the latter includes ribotyping (23), 82 
DiversiLab analysis (42), direct PCR assays (43) and protein-encoding gene sequencing (18, 83 
20, 21, 44). Unfortunately, many of these approaches suffer from specificity or sensitivity 84 
limitations, which constrain their diagnostic value. For example, previously described direct 85 
PCR assays do not differentiate IA1 from type IA2 or IC, or target type III strains (43); they 86 
may also give ambiguous results (44). Single locus nucleotide sequencing, which to date has 87 
been primarily based on the recA housekeeping and tly methyltransferase/ haemolysin genes, 88 
is robust for identification of types I, II and III, but displays reduced specificity for 89 
differentiation of type IB strains from type IA2 and some strains within the type IA1 clade as 90 
they contain identical alleles due to horizontal gene transfer (HGT) (20, 21, 23, 38). More 91 
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 5 
recently, mAb typing with antibodies targeting types IA, IC and II, combined with recA 92 
sequence analysis has obviated this problem, facilitating accurate differentiation of type IB 93 
from all type IA strains (45). MALDI-TOF MS has also been described as a valuable and 94 
powerful approach for rapid and high throughput phylogroup identification, but currently will 95 
not differentiate type IA1 from IA2 (41); furthermore, the technology is not available within 96 
all laboratories. At present, Multilocus Sequence Typing (MLST) of P. acnes (20, 21) still 97 
represents the clear gold standard for unambiguous phylogroup identification, as well as 98 
individual strain resolution (Table S1), and offers significant advantages over comparable 99 
high resolution gel-based typing methodologies, including Random Amplification of 100 
Polymorphic DNA (RAPD) (46) and Pulse Field Gel Electrophoresis (PFGE) (47, 48) which 101 
have also been applied to this bacterium. The MLST method is, however, technically 102 
demanding, time consuming and expensive, especially when analysing multiple isolates. 103 
Consequently, and as a result of the growing interest surrounding the role of this microbe in 104 
disease, there is a need for a rapid, less labour intensive and inexpensive method for typing 105 
and stratification of P. acnes isolates, thus facilitating future molecular epidemiological and 106 
phylogenetic studies. Against this background, we now describe the development and 107 
validation of a multiplex touchdown PCR assay that can be used for quick, high-throughput 108 
and accurate molecular confirmation of P. acnes isolates combined with parallel disclosure of 109 
their phylogeny. This assay should prove valuable for researchers and, along with MLST, 110 
form part of a ‘molecular typing toolbox’ that can be used for the analysis of P. acnes 111 
isolates. 112 
113 
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 6 
MATERIALS AND METHODS 114 
Bacterial strains and growth. A total of 312 P. acnes isolates were used to validate the 115 
multiplex PCR (145 type IA1; 20 type IA2, 65 type IB, 7 type IC, 45 type II and 30 type III). 116 
These isolates were previously recovered from a wide range of clinical sources and healthy 117 
skin, and their phylogroup status determined using an MLST scheme based on eight genes 118 
(38). A representative sample of isolates from each group were also analysed by mAb typing 119 
as previously described (18), and their reactivity was consistent with their phylogroup 120 
designations based on MLST. Genomic DNA from a panel of 49 isolates representing 34 121 
medically relevant bacterial species, and including other human Propionibacterium species, 122 
was also used in the assessment of multiplex specificity (Table S2). All bacterial strains were 123 
maintained at -80 °C in brain heart infusion (BHI) broth, containing 12% (v/v) glycerol. 124 
Anaerobic isolates were cultured in BHI and on anaerobic horse blood agar (ABA) plates 125 
(Oxoid Ltd, Hampshire, UK) at 37 °C in an anaerobic cabinet (Mark 3; Don Whitley 126 
Scientific) under an atmosphere of 10% H2, 10% CO2, 80% N2. Aerobic bacteria were 127 
cultured on horse blood agar at 37 °C.  128 
 129 
Development of phylogroup-specific primers. Housekeeping gene sequences representing 130 
aroE (424bp), atpD (453bp), gmk (400bp), guaA (493bp), lepA (452bp) and sodA (450bp) 131 
were retrieved from the P. acnes MLST database (http://pubmlst.org/pacnes/). Sequences for 132 
each gene were then aligned using MEGA v5.1 software and inspected for phylogroup-133 
specific polymorphisms. Phylogroup-specific genomic regions were also investigated using 134 
the progressiveMauve algorithm (v2.3.1) and the Artemis Comparison Tool (ACT; 135 
http://www.sanger.ac.uk/Software/ACT/) using whole genome sequences (WGS) currently 136 
available as part of the HMP, as well as other sequencing projects 137 
(http://www.ncbi.nlm.nih.gov/genome/genomes/1140) (Table S1). Based on these analyses, 138 
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 7 
phylogroup-specific primer sets were developed as listed in Table 1.  139 
 140 
Multiplex PCR analysis. Bacterial genomic DNA was prepared using an AquaGenomic
TM
 141 
kit (Multi Target Pharmaceuticals). PCR amplification was carried out using a MultiGene 142 
thermocycler (Labnet International Inc, UK). Samples contained 1 x PCR buffer, 200 µM of 143 
each deoxynucleoside triphosphate (Invitrogen Life Technologies, UK), six primer sets 144 
targeting each phylogroup at concentrations described in Table 1, 1.5 mM MgCl2, 1x 145 
RediLoad
TM
 (Invitrogen Life Technologies), 1.25 U Taq DNA polymerase (Invitrogen Life 146 
Technologies) and 1l of pure genomic DNA preparation in a total volume of 10 l. Samples 147 
were initially heated at 94°C for 1 min, followed by 14 cycles consisting of 94°C for 30 s, 148 
66°C (decreasing incrementally 0.3°C per cycle) for 30 s, and 72°C for 1 min, followed by 11 149 
cycles at 94°C for 30 s, 62°C for 30 s and 72°C for 1 min, culminating with a final cycle at 150 
72°C for 10 min. A negative control (PCR water)
 
and six positive control samples 151 
representing all phylogroups were included in all experiments. PCR products were analysed 152 
by electrophoresis on 1.5% (w/v) agarose gels containing 1x Tris-acetate-EDTA buffer. 153 
Molecular size markers were run in parallel on all gels. Resolved DNA products were stained 154 
with 1x GelRed
TM
 Nucleic Acid Gel stain (Cambridge Biosciences, UK).  155 
 156 
Nucleotide sequencing. Sequencing reactions were performed using BigDye
®
 reaction 157 
terminator cycle sequencing kits (version 1.1) (Life Technologies, UK) according to the 158 
manufacturer’s instructions. Samples were then analysed on an ABI PRISM 3100 genetic 159 
analyser capillary electrophoresis system (Life Technologies). 160 
 161 
Split decomposition analysis. Split decomposition analysis was performed using SplitsTree4 162 
version 4.13.1 (49)  163 
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 8 
RESULTS   164 
Primer design. Polymorphisms in multiple aligned sequences of the sodA gene specific for 165 
types IA2 and IB, and atpD and recA genes specific to types II and III, respectively, were 166 
identified as candidate regions for primer development (Table 1). Primers were also 167 
developed against the ATP-binding component (ATPase; GenBank accession no. 168 
ABB20821.1) of a previously described ABC-type peptide uptake operon (DQ208967) 169 
present in the closely related type IA1, IA2 and IC groups, but absent in type IB, II and III 170 
strains (Table 1) (43). This operon also includes genes encoding permeases (ABB20819.1; 171 
ABB20820.1) and a solute binding protein (ABB20823.1), alongside genes for a glycoside 172 
hydrolase (ABB20818.1) and chitinase (ABB20824). For type IC strains, we developed a 173 
primer set targeting a Fic family-toxin gene located on an approximately 7.3 kb genomic 174 
fragment present in the draft genome sequences of the type IC strains PRP-38 175 
(TICEST70_07737) and HL097PA1 (HMPREF9344_02057), but not other phylogroups 176 
(Table 1). This genomic fragment also contained restriction enzyme-associated genes and a 177 
gene encoding a DEAD/DEAH box helicase (HMPREF9344_02061). Our previously 178 
described P. acnes-specific 16S rDNA-based primers were also included in the assay to 179 
confirm species identity (Table 1) (11, 50). Primer sets incorporated phylogroup-specific 180 
mismatches at the 3’ end, and elsewhere in the sequence when available, and were designed 181 
to have identical annealing temperatures where possible, and to generate amplicons with 182 
characteristic size differences that would facilitate easy visual identification on a gel after 183 
multiplexing. 184 
 185 
Multiplex PCR development and validation. Each individual phylogroup-specific primer 186 
set was initially examined against a small panel of strains (n=40) representing types IA1, IA2, 187 
IB, IC, II and III. Amplicons of predicted size were correctly generated from the targeted 188 
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 9 
phylogroup, and no products were unexpectedly observed in divisions outside those targeted 189 
by the primers (data not shown). The identity of each PCR product was confirmed by direct 190 
nucleotide sequence analysis (data not shown). Each primer set was then combined into a 191 
single multiplex touchdown PCR reaction, which was optimised for final primer and MgCl2 192 
concentrations, as well as amplification cycles, as outlined in the methods section. As the 193 
sodA primers PAMp-3/ PAMp-4 had a lower annealing temperature (62°C) than all the other 194 
primer sets (66°C), a touchdown PCR approach was adopted to ensure satisfactory, highly 195 
specific amplification of all gene targets within the assay. Using this approach, it proved 196 
possible to reliably determine the phylogeny of an isolate based on the combination of 197 
different phylogroup-specific amplification products as illustrated in Fig 1.  198 
To assess the sensitivity and specificity of the multiplex assay, especially in relation 199 
to primers targeting genomic regions that were presumptively present/absent between 200 
phylogenetic divisions based on in silico analysis of WGS data, we screened a large panel of 201 
312 P. acnes isolates previously characterised by MLST, and representing a total of 97 202 
unique sequence types (ST) covering all the phylogroups. Based on this current sample 203 
cohort, the multiplex PCR displayed 100% specificity and 100% sensitivity for the detection 204 
of isolates within each targeted phylogroup (Table 2); no cross-reactivity with isolates from a 205 
wide range of other medically relevant bacterial species was observed, including other 206 
cutaneous Propionibacterium and Staphylococcus species (Table 2 and Table S2).  207 
 208 
DISCUSSION: 209 
Since the 16S rRNA gene of P. acnes has very high intraspecific sequence identity (18, 19), it 210 
afforded little opportunity for the design of phylogroup-specific primers on which we could 211 
base our multiplex assay. As an alternative, we examined various protein-encoding 212 
housekeeping loci, and interrogated available whole genome sequences representing all 213 
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known phylogroups, for unique genetic regions that could act as platforms for assay 214 
development. By adopting this approach, we were able to design primers based on atpD 215 
(PAMp-7/ PAMp-8) and recA (PAMp-9/ PAMp-10) housekeeping loci that specifically 216 
identified phylogroup II and III strains, respectively. Type IC strains were identified by their 217 
reaction with the primers PAMp-5/ PAMp-6 that targeted a Fic family toxin gene present on 218 
a genomic region only found in type IC strains; such toxins form part of toxin-antitoxin (TA) 219 
systems which are believed to be important in bacterial persistence in response to specific 220 
environmental stresses, as well as pathogenicity (51). While types IA1, IA2 and IC all reacted 221 
with primers targeting an ATPase gene (PAMp-1/ PAMp-2) that was part of an ABC-type 222 
peptide uptake operon, differentiation of type IA2 and IC strains from IA1, and each other, 223 
was achieved due to their separate reaction with the primers PAMp-3/ PAMp-4 and PAMp-5/ 224 
PAMp-6, respectively. The restriction of an ABC-type peptide uptake operon containing 225 
chitinase to type IA and IC divisions, but not other phylogroups, is of particular interest and 226 
may be potentially advantageous for the cleavage of chitin from the cell wall of the fungus 227 
Malassezia and/or Demodex mites, which also colonise human skin (20). Since type IA2 228 
isolates contain alleles of the sodA locus that are identical (allele 4), or very closely related 229 
(allele 5), to those present in all type IB strains (21, 38), both phylogenetic groups displayed 230 
reaction with the sodA primer pair PAMp-3/ PAMp-4. Their identity was, however, easily 231 
determined based on differential reaction with the ATPase primers PAMp-1/PAMp-2; type 232 
IB isolates show no product with the latter primer set. Interestingly, as the type IA2 clade 233 
shares recA and tly alleles with type IB isolates it provides evidence for HGT of large 234 
genomic fragments in the natural history of the bacterium (20, 21, 38). 235 
By combining these different primer sets, along with the 16S rDNA primers PArA-1 236 
and PArA-2, into a single multiplex assay, we have been able to provide researchers with a 237 
robust method for rapid, high-throughput molecular identification of presumptive P. acnes 238 
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isolates, combined with valuable phylogenetic typing information. This assay should prove a 239 
useful tool for epidemiological studies, as well as stratification of isolates for various 240 
downstream analyses. It offers enhanced discrimination and specificity over comparable 241 
molecular (PCR, single gene sequencing) and mAb typing approaches which have been 242 
previously described in the literature, and is also less time consuming, especially over 243 
methods that require multiple, separate analyses on each isolate. The multiplex PCR will 244 
facilitate future retrospective and prospective studies aimed at investigating the association of 245 
specific phylogenetic lineages with different human infections, clinical conditions and 246 
antibiotic resistance, and will now also provide a technically undemanding way to rapidly 247 
map multiple isolates from the same clinical sample so that the presence and pattern of mixed 248 
population types can be determined, especially at different body sites/ niches. The method 249 
should also provide a useful complement to the more detailed, and technically complicated, 250 
study of P. acnes populations in complex microbiotas based on metagenomic analysis (23). 251 
Although in this study we utilized purified genomic DNA as our template for multiplex PCR, 252 
future optimization of the method for direct analysis of bacterial colonies (colony PCR) 253 
would further enhance the rapid nature of the assay. Furthermore, of the P. acnes isolates 254 
tested, numbers representing types IA2 and IC were lower than those from other phylogroups, 255 
especially types IC which are infrequently recovered. As a consequence, further analysis of 256 
additional isolates from these clusters will be important to confirm the multiplex PCR 257 
specificity and sensitivity results for these types.  258 
To date, our understanding of P. acnes population structure within and between 259 
different body habitats of individuals is poor. These sites not only include various areas of, 260 
and regions within, the skin, but also the oral cavity and genitourinary tract. Such data may 261 
prove especially valuable in our attempts to better understand the potential origin of different 262 
lineages associated with clinical samples, particularly in relation to blood culture, and 263 
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whether the pattern of isolates recovered from primary surgical samples matches those on the 264 
overlying/ surrounding skin, thus indicating potential contamination. In the surgical setting, 265 
current methods used for pre-operative skin antisepsis do not always prevent microbial 266 
contamination of surgical wounds with viable bacteria (52, 53). Although acute surgical site 267 
infections may not ensue due to effective i.v. prophylactic antibiotic administration, these 268 
bacteria may still cause downstream chronic biofilm-associated implant infection. It seems 269 
reasonable to assume that contamination from the skin would result in a mixture of different 270 
phylogenetic groups within a sample, while significant counts of a monotype may be more 271 
indicative of infection. Under such circumstances, the multiplex could prove a valuable and 272 
simple molecular screening tool to highlight such a scenario, and thus aid the diagnosis of 273 
biofilm-associated implant infections and bacteremia etc within a clinical setting (54). 274 
Furthermore, the detection of phylogroups with a potentially greater propensity to cause 275 
infection within a clinical sample, such as IA1, may also be more indicative of infection when 276 
compared to phylogroups, such as types II and III, believed to be associated with a more 277 
commensal existence (21). 278 
To date, two MLST schemes based on eight (MLST8) and nine (MLST9) different 279 
protein-encoding genes have been described for P. acnes (20, 21); the methods are essentially 280 
concordant in respect to the clustering of strains into different clonal complexes (CCs), 281 
although more subtle differences in the resolution of particular lineages within these CCs 282 
exist (21, 38). While MLST provides high resolution typing of P. acnes, and generates not 283 
only phylogroup information, but also ST data that is highly amenable to phylogenetic and 284 
evolutionary analyses, the method is laborious and time consuming when investigating 285 
multiple isolates. The development of new approaches to help streamline the MLST 286 
workflow are very attractive, and recently we described how cross-referencing a refined four 287 
gene MLST allelic profile to the full eight gene versions available in the MLST database at 288 
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http://pubmlst.org/pacnes/ could be used to correctly predict and assign phylogroup, clonal 289 
complex and, in the vast majority of cases, ST for a P. acnes isolate (38). In this context, 290 
rapid pre-screening of isolates by multiplex PCR could also prove an extremely valuable way 291 
to maximise the number of genetically diverse isolates selected for downstream MLST 292 
analyses, thus reducing sequencing costs. Furthermore, MLST and whole genome analyses 293 
have shown that types IA2, IB, IC and III represent tight phylogenetic clusters, especially 294 
when compared to types IA1 and II (21, 22, 38) (Table S1); this is reflected in a more 295 
restricted number of STs, some of which are highly dominant and widely disseminated. As a 296 
consequence, high resolution MLST typing after multiplex PCR provides less phylogenetic 297 
information for types IA2, IB, IC and III isolates when compared to types IA1 and II which 298 
are genetically more heterogeneous and contain deeper levels of phylogenetic structure. In 299 
keeping with the desirability of a simpler approach to high resolution typing of P. acnes, a 300 
single locus typing scheme (SLST) for the bacterium based on nucleotide sequencing of an 301 
amplified target region (484 bp) immediately upstream of the camp1 gene (identified by a 302 
genome mining approach) was described during the preparation of this manuscript (55). 303 
While the MLST8 and MLST9 schemes resolve a greater number of genotypes than SLST 304 
(Table S1), the latter method does correctly cluster isolates into phylogenetic groupings that 305 
are congruent with a core genome reference tree (55). In addition, there is little evidence of 306 
recombination within the locus based on a network tree analysis (phi test p=0.976) (Fig S1). 307 
The SLST method is, therefore, a valuable complement, and technically simpler approach, to 308 
current MLST methods of typing P. acnes.   309 
Rapid screening of isolates by multiplex PCR will also aid the discovery of novel taxa 310 
via atypical PCR reactions. For example, sole reaction with the 16S rDNA primer set PArA-311 
1/ PArA-2 may indicate a new closely related species of Propionibacterium with high 16S 312 
rDNA identity to P. acnes, or a novel P. acnes phylogroup or ST that contains base 313 
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mismatches at primer binding sites within the protein encoding genes of the assay. Indeed, as 314 
a direct result of multiplex PCR screening of skin derived isolates, we have recently come 315 
across such a scenario and identified a new Propionibacterium species that has very high 16S 316 
rDNA identity to P. acnes (and reacts with PArA-1/ PArA-2) but is quite distinct from the 317 
latter, and other cutaneous propionibacteria, based on whole genome analysis (currently 318 
unpublished). 319 
In conclusion, the multiplex PCR described here facilitates rapid molecular 320 
confirmation of presumptive P. acnes isolates along with parallel phylogenetic typing. It 321 
should provide researchers with a flexible typing tool that can be used in isolation, or as an 322 
adjunct to more detailed sequence-based analysis depending on the epidemiological questions 323 
being asked and resolution required. It is also a technically simple methodology for the rapid 324 
analysis of mixed P. acnes populations, and should therefore help improve our understanding 325 
of the role of different P. acnes lineages in clinical conditions.  326 
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 522 
FIGURE LEGEND.  523 
 524 
FIG 1. Multiplex PCR analysis of P. acnes strains representing different phylogroups and 525 
STs. Bottom lanes (left to right): 1, hdn-1 (ST1; type IA1); 2, PRP-60 (ST20; type IA1); 3, 526 
76793 (ST101; type IA1); 4, Pacn33 (ST2, type IA2); 5, P.acn17 (ST2, type IA2); 6, P. acn31 527 
(ST2, type IA2); 7, 6609 (ST5, type IB); 8, VA3/4 (ST78, type IB); 9, 74874 (ST43, type IB); 528 
10, PRP-38 (ST70, type IC); 11, PV66 (ST85, type IC); 12, 5/1/3 (ST107, type IC); 13, 529 
ATCC11828 (ST27, type II); 14, VA2/9N (ST28, type II); 15, 6187 (ST30, type II); 16, 12S 530 
(ST32, type III); 17, Asn12 (ST33, type III); 18, Asn10 (ST81, type III); 19, P. avidum 531 
44067; Ma molecular size markers. ST is based on the eight-gene MLST scheme of 532 
McDowell et al. (21) and database at http://pubmlst.org/pacnes/. Gene amplicons (left to 533 
right): a, 16S rRNA; b, ATPase; c, sodA; d, toxin; e, atpD; f, recA.  534 
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TABLE 1. Multiplex PCR primer characteristics  535 
a
For protein-encoding housekeeping genes, primers relate to positions within the open reading frame.  For the 16S rRNA gene, primers relate to positions 536 
within the sequence for NCTC737 (Genbank accession no. AB042288) 537 
Primers
a
 Specificity Gene 
targeted 
Sequence (5’-3’) Position Concentration Annealing  
Temp (°C) 
Amplicon 
 size (bp) 
PArA-1 
PArA-2 
P. acnes 16S rRNA AAGCGTGAGTGACGGTAATGGGTA 
CCACCATAACGTGCTGGCAACAGT 
442-465 
1118-1095 
0.2µM 66 677 
PAMp-1 
PAMp-2 
IA1/IA2/IC ATPase GCGTTGACCAAGTCCGCCGA 
GCAAATTCGCACCGCGGAGC 
 
451-470 
944-925 
0.25µM 66 494 
PAMp-3 
PAMp-4 
IA2/IB sodA CGGAACCATCAACAAACTCGAA 
GAAGAACTCGTCAATCGCAGCA 
168-189 
312-291 
0.6µM 62 145 
PAMp-5 
PAMp-6 
IC Toxin,  
Fic family  
AGGGCGAGGTCCTCTTCTACCAGCG 
ACCCTCCAACTGCAACTCTCCGCCT 
 
17-41 
321-297 
0.1µM 66 305 
PAMp-7 
PAMp-8 
II atpD TCCATCTGGCCGAATACCAGG 
TCTTAACGCCGATCCCTCCAT 
339-360 
689-669 
0.15µM 66 351 
PAMp-9 
PAMp-10 
III recA GCGCCCTCAAGTTCTACTCA 
CGGATTTGGTGATAATGCCA 
 
641-660 
865-846 
0.25µM 66 225 
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 538 
 539 
 540 
TABLE 2. Multiplex PCR assay accuracy  541 
 542 
 543 
 544 
 545 
 546 
 547 
 548 
 549 
 550 
 551 
 552 
 553 
 554 
 555 
 556 
 557 
 558 
 559 
 560 
 561 
 
562 
a
All others relates to P. acnes isolates outside the target phylogroup,  563 
plus 49 isolates from other medically relevant species  564 
b
Positive relates to detection of the expected amplification pattern under  565 
consideration, while negative indicates that one of the alternate phylogroup  566 
profiles was detected, or no reaction was observed in the case of other spp 567 
 Number of isolates
b
 Sensitivity Specificity 
Phylogroup
a
 Positive Negative  (%)  (%) 
IA1 145/145 0/145 100 100 
all others 0/216 216/216   
     
IA2 20/20 0/20 100 100 
all others 0/341 341/341   
     
IB 65/65 0/65 100 100 
all others 0/296 296/296   
     
IC 7/7 0/7 100 100 
all others 0/354 354/354   
     
II 45/45 0/45 100 100 
all others 0/316 316/316   
     
III 30/30 0/30 100 100 
all others 0/331 331/331   
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